MedTrace Logo

GeneSearch Breast Lymph Node (BLN) Assay Timing Study

NCT00595023 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 233

Last updated 2016-01-12

No results posted yet for this study

Summary

This study is designed to collect data about the amount of time required to use the assay in clinical-use conditions.

Conditions

Interventions

DEVICE

GeneSearch™ Breast Lymph Node (BLN) Assay

The GeneSearch™ BLN Assay is a real time Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) assay that detects the presence of breast tumor cell metastasis in lymph nodes through the detection of gene expression markers present in breast tissue, but not in nodal tissue (cell type specific messenger RNA).

Sponsors & Collaborators

  • Janssen Diagnostics, LLC

    lead INDUSTRY

Principal Investigators

  • Scott U Adams, MS · Ortho-Clinical Diagnostics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595023 on ClinicalTrials.gov